USD $402.00
Prolia or Xgeva (Denosumab) is a medication used to treat bone-related conditions. It is administered via a single prefilled syringe containing 60mg/ml of the active ingredient Denosumab.
Denosumab works by inhibiting the development and activity of osteoclasts, the cells responsible for bone resorption. This helps to strengthen bones and reduce the risk of fractures.
Prolia is primarily used to treat osteoporosis in postmenopausal women and men at increased risk of fractures. Xgeva is used to prevent skeletal-related events in patients with bone metastases from solid tumors and to treat giant cell tumor of bone.
The medication is administered through a subcutaneous injection. Healthcare professionals typically perform the injection, ensuring precise dosage and monitoring.
Denosumab provides significant benefits including reduced risk of fractures, increased bone density, and effective management of bone-related conditions in patients with osteoporosis or cancer-related bone issues.
Common side effects may include back pain, musculoskeletal pain, hypercholesterolemia, and urinary tract infections. It is important to discuss any side effects with a healthcare provider.
Individuals with hypocalcemia or those allergic to any component of the formulation should not use this medication. A healthcare provider can offer guidance based on individual medical history.
Before starting treatment, discuss any existing health conditions, ongoing medications, and potential allergies with your healthcare provider to ensure the safe use of Denosumab.
Store the prefilled syringe in a refrigerator, protected from light. Do not freeze. Ensure it is kept out of reach of children and pets.
Health Guides